NCT00203086
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
Not specified
Clinical trial condition
Relapsing Remitting Multiple Sclerosis
Explore clinical trials studying Relapsing Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
84 public trials
6 recruiting studies
Relapsing Remitting Multiple Sclerosis trial results
NCT00594087
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +14 more
- Locations
-
- University of Vermont Burlington, Vermont, United States
NCT00382629
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
Not specified
Completed
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
NCT00534261
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Coordinating Research Site Sijsele-Damme, Belgium
- Coordinating Research Site Esch-sur-Alzette, Luxembourg
- Coordinating Research Site Glasgow, Scotland, United Kingdom